APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $15.8M invested in Aptevo Therapeutics in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$1.5M
2
-$1.21M
3
-$815K
4
FM
Fondren Management
Texas
-$292K
5
AA
AQR Arbitrage
Connecticut
-$274K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$44K
27
$40K
28
$34K
29
$32K
30
$32K
31
$28K
32
$27K
33
$27K
34
$26K
35
$24K
36
$20K
37
$13K
38
$10K
39
$8K
40
$5K
41
$5K
42
$4K
43
$3K
44
$3K
45
$1K
46
$103
47
$16
48
–
49
–
50
–
1
2
3